홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
NPCE
#2528
Neuropace, Inc. Common Stock
14.580
0
-0.95%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
-0.95%
월간 변동
-9.97%
6달 변화
+37.81%
년간 변동율
+37.81%
이전 종가
14.720
0
Open
14.580
0
Bid
Ask
Low
14.580
0
High
14.580
0
양
30
마켓
주식
헬스케어
NPCE
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
29.85 M
32.56 M
32.8 M
33.08 M
33.31 M
—
Valuation ratios
Enterprise value
192.62 M
350.92 M
376.07 M
345.67 M
322.75 M
1.4 B
Price to earnings ratio
-7.04
-12.03
-14.99
-13.59
-13.93
-54.54
Price to sales ratio
2.54
4.08
4.3
3.82
3.41
15.61
Price to cash flow ratio
-11.78
-18.16
-20.53
-21.14
-19.56
-79.39
Price to book ratio
3.5
40.67
7.09
5.6
4.64
58.01
Enterprise value to EBITDA ratio
-8.52
-16.52
-19.93
-17.76
-18.14
-72.34
Profitability ratios
Return on assets %
0.06
0.06
0.06
0.08
0.03
0.23
Return on equity %
0.56
0.66
0.27
0.45
0.19
1.56
Return on invested capital %
60.48
—
67.6
88.98
34.72
—
Gross margin %
73.22
75.41
76.99
77.09
77.39
306.88
Operating margin %
20.15
17.02
22.85
29.01
9.51
78.39
EBITDA margin %
-19.45
-17
-22.42
-28.35
-8.88
-76.65
Net margin %
25.89
24.46
29.25
36.78
12.78
103.27
Liquidity ratios
Quick ratio
4.77
4.48
5.7
4.51
3.94
18.64
Current ratio
5.59
5.37
6.63
5.47
4.86
22.33
Inventory turnover
0.48
0.41
0.38
0.36
0.36
1.52
Asset turnover
0.22
0.22
0.22
0.22
0.26
0.92
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.62
0.63
0.54
0.55
0.55
2.27
Long term debt to total equity ratio
6.03
7.43
2.46
3.02
3.17
16.08
Per share metrics
Operating cash flow per share
0.06
0.16
0.24
0.06
0.06
0.52
EBIT per share
-0.14
-0.13
-0.16
-0.21
-0.08
-0.58
EBITDA per share
-0.14
-0.13
-0.16
-0.2
-0.07
-0.56
Total debt per share
—
—
—
—
—
—
Cash per share
1.93
1.81
2.11
1.89
1.81
7.62
Net current asset value per share
2.8
2.79
3.1
2.85
2.88
11.62
Tangible book value per share
0.33
0.28
0.77
0.59
0.56
2.2
Working capital per share
2.3
2.27
2.63
2.33
2.29
9.52
Book value per share
0.33
0.28
0.77
0.59
0.56
2.2
뉴스
LivaNova (LIVN) Tops Q4 Earnings and Revenue Estimates
Sight Sciences, Inc. (SGHT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
NeuroPace, Inc. (NPCE) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Pacific Biosciences of California (PACB) Reports Q4 Loss, Beats Revenue Estimates
신경페이스(NPCE) 목표 주가, Leerink Partners, 19달러에서 20달러로 상향
NeuroPace stock price target raised to $20 from $19 at Leerink Partners
NeuroPace stock price target raised to $19 from $18 at H.C. Wainwright
NeuroPace, Inc. (NPCE) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
뉴로페이스, 4분기 호실적에 UBS ’매수’ 등급 재확인 후 주가 상승
NeuroPace stock rises as UBS reiterates Buy rating after strong Q4 revenue
뉴로페이스, 2025년 25% 매출 성장 보고 및 꾸준한 성장 전망
NeuroPace reports 25% revenue growth for 2025, projects steady growth